189 related articles for article (PubMed ID: 3896181)
21. Panel discussion: hyperuricemia as a risk factor.
Watts RW; Kelley WN; Rapado A; Scott JT; Seegmiller JE; de Vries A; Wyngaarden JB; Zöllner N
Adv Exp Med Biol; 1977; 76B():342-64. PubMed ID: 855760
[No Abstract] [Full Text] [Related]
22. [Formation of urinary calculi and uric acid findings in children with leukemia].
Moe PJ
Tidsskr Nor Laegeforen; 1970 Jun; 90(11):1201-5. PubMed ID: 5450743
[No Abstract] [Full Text] [Related]
23. Long-term treatment of gout with "allopurinol".
Michotte JL; Burtonboy G
Acta Rheumatol Scand; 1968; 14(1):71-8. PubMed ID: 5649436
[No Abstract] [Full Text] [Related]
24. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
Rapado Errazti A
Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):304-6. PubMed ID: 5997999
[No Abstract] [Full Text] [Related]
25. Depletion of erythrocyte phosphoribosylpyrophosphate in man.
Fox IH; Wyngaarden JB; Kelley WN
N Engl J Med; 1970 Nov; 283(22):1177-82. PubMed ID: 4319625
[No Abstract] [Full Text] [Related]
26. [Simplification of allopurinol treatment].
Zöllner N; Griebsch A
MMW Munch Med Wochenschr; 1974 Sep; 116(39):1691-2. PubMed ID: 4216779
[No Abstract] [Full Text] [Related]
27. [Hyperuricosuria controlled with allopurinol: a new concept in the prevention of uric acid calculi].
Anderson EE; Rudles RW; Silberman HR; Martinez SJ
Rev Venez Urol; 1970; 22(3):265-73. PubMed ID: 5519834
[No Abstract] [Full Text] [Related]
28. [Allopurinol in the treatment of gout: initial results].
Serre H; Simon L; Claustre J
Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049
[No Abstract] [Full Text] [Related]
29. Basic sciences in medicine: the example of gout.
Stetten D
N Engl J Med; 1968 Jun; 278(24):1333-6. PubMed ID: 5648600
[No Abstract] [Full Text] [Related]
30. [Allopurinol].
Scott JT
Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893
[No Abstract] [Full Text] [Related]
31. Allopurinol in treatment of patients with gout and chronic renal failure.
Bowie EA; Simmonds HA; North JD
N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
[No Abstract] [Full Text] [Related]
32. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy and comparative biochemistry: G. H. A. Clowes memorial lecture.
Hitchings GH
Cancer Res; 1969 Nov; 29(11):1895-903. PubMed ID: 4982548
[No Abstract] [Full Text] [Related]
34. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
Watts RW; Snedden W; Parker RA
Clin Sci; 1971 Aug; 41(2):153-8. PubMed ID: 5564305
[No Abstract] [Full Text] [Related]
35. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
Holländer E; Schwarczmann P
Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
[No Abstract] [Full Text] [Related]
36. [Allopurinol in the treatment of hyperuricemia and chronic gout].
Benedetti A; Nardini A; Busonera G
Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
[No Abstract] [Full Text] [Related]
37. Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
Kuzell WC; Seebach LM; Glover RP; Jackman AE
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):634-42. PubMed ID: 5335061
[No Abstract] [Full Text] [Related]
38. Allopurinol in the treatment of uraemic patients with gout.
Wilson JD; Simmonds HA; North JD
Ann Rheum Dis; 1967 Mar; 26(2):136-42. PubMed ID: 6023695
[No Abstract] [Full Text] [Related]
39. [Kidney involvement in gout].
Stein G
Beitr Rheumatol; 1972; 18():61-7. PubMed ID: 4649120
[No Abstract] [Full Text] [Related]
40. Gout and uric acid metabolism.
Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
